AcquisitionsMay 18, 2026, 07:31 AM
Catheter Precision Acquires FLYTE, Reports Q1 Revenue $432K
AI Summary
Catheter Precision, Inc. completed the acquisition of Fly Flyte, Inc. in Q1 2026, establishing a new private aviation segment alongside its cardiac electrophysiology business. The company reported a significant increase in total revenues to $432K for the quarter, up from $143K year-over-year, and an improved net loss of $1.69M compared to $4.05M in the prior year. Despite these improvements and recent financing activities, management issued a going concern warning due to recurring losses and negative operating cash flows.
Key Highlights
- Acquired 100% of Fly Flyte, Inc. in Q1 2026, establishing a new private aviation segment.
- Total revenues increased 202% to $432K for Q1 2026, from $143K in Q1 2025.
- Net loss improved to $(1.69)M in Q1 2026, from $(4.05)M in Q1 2025.
- Net loss per share improved to $(1.39) from $(6.81) year-over-year.
- Cash and cash equivalents rose to $441K as of March 31, 2026, from $88K at Dec 31, 2025.
- Raised $3.7M gross proceeds from common stock and preferred stock issuance in Q1 2026.
- Recognized $9.7M in goodwill allocated to the new private aviation segment.
- Issued a going concern warning due to recurring losses and negative cash flows.
Price Impact
More from VTAK